| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |
From the Department of Soft Tissue Pathology,*
Armed
Forces Institute of Pathology, Washington, DC; the Department of
Pathology,
Haartman Institute of the
University of Helsinki, Helsinki, Finland; the Department of
Pathology,§
Maria Sklodowska-Curie Memorial
Institute, Krakow, Poland; the Chair of Oncology,¶
Medical University of Lodz, Lodz, Poland; the Department of
Pathology,||
George Washington University Hospital,
Washington, DC; the Division of Gastrointestinal
Pathology,**
Armed Forces Institute of Pathology,
Washington, DC; and the Department of Biology and
Genetics,
Medical University of Gdansk,
Gdansk, Poland
Gastrointestinal stromal tumors (GISTs), the most common mesenchymal tumors of the gastrointestinal tract, typically express the KIT protein. Activating mutations in the juxtamembrane domain (exon 11) of the c-kit gene have been shown in a subset of GISTs. These mutations lead into ligand-independent activation of the tyrosine kinase of c-kit, and have a transforming effect in vitro. Several groups have studied the clinical implication of the c-kit mutation status of exon 11 in GISTs and a possible relationship between c-kit mutations and malignant behavior has been established. Recently, a 1530ins6 mutation in exon 9 and missense mutations, 1945A>G in exon 13 of the c-kit gene were reported. The frequency and clinical importance of these findings are unknown. In this study we evaluated 200 GISTs for the presence of mutations in exons 9 and 13 of c-kit. Six cases revealed 1530ins6 mutation in exon 9 and two cases 1945A>G mutation in exon 13. All tumors with mutations in exon 9 and 13 lacked mutations in exon 11 of c-kit. None of the analyzed tumors had more than one type of c-kit mutation. All but one of the eight tumors with mutations in exon 9 or 13 of the c-kit gene were histologically and clinically malignant. All four of six cases with exon 9 mutation of which location of primary tumor was known, were small intestinal, suggesting that this type of mutation could preferentially occur in small intestinal tumors. Exon 9 and 13 mutations seem to be rare, and they cover only a small portion (8%) of the balance of GISTs that do not have mutations in exon 11 of c-kit. This finding indicates that other genetic alterations may activate c-kit in GISTs, or that KIT is not activated by mutations in all cases.
This article has been cited by other articles:
 |
|
 |
|
  C. Braconi, R. Bracci, I. Bearzi, F. Bianchi, A. Costagliola, R. Catalani, A. Mandolesi, R. Ranaldi, E. Galizia, S. Cascinu, et al. KIT and PDGFR{alpha} mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study Ann. Onc., April 1, 2008; 19(4): 706 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Desai, S. Shankar, M. C. Heinrich, J. A. Fletcher, C. D. Fletcher, J. Manola, J. A. Morgan, C. L. Corless, S. George, K. Tuncali, et al. Clonal Evolution of Resistance to Imatinib in Patients with Metastatic Gastrointestinal Stromal Tumors Clin. Cancer Res., September 15, 2007; 13(18): 5398 - 5405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Q.M. Chow and S. G. Eckhardt Sunitinib: From Rational Design to Clinical Efficacy J. Clin. Oncol., March 1, 2007; 25(7): 884 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lasota, B. Wasag, S. E. Steigen, J. Limon, and M. Miettinen Improved Detection of KIT Exon 11 Duplications in Formalin-Fixed, Paraffin-Embedded Gastrointestinal Stromal Tumors J. Mol. Diagn., February 1, 2007; 9(1): 89 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Schurr, S. Wolter, J. Kaifi, U. Reichelt, H. Kleinhans, R. Wachowiak, E. Yekebas, T. Strate, V. Kalinin, R. Simon, et al. Microsatellite DNA Alterations of Gastrointestinal Stromal Tumors Are Predictive for Outcome Clin. Cancer Res., September 1, 2006; 12(17): 5151 - 5157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Rossi, I. Ehlers, V. Agosti, N. D. Socci, A. Viale, G. Sommer, Y. Yozgat, K. Manova, C. R. Antonescu, and P. Besmer Oncogenic Kit signaling and therapeutic intervention in a mouse model of gastrointestinal stromal tumor PNAS, August 22, 2006; 103(34): 12843 - 12848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Martin, A. Poveda, A. Llombart-Bosch, R. Ramos, J. A. Lopez-Guerrero, J. G. del Muro, J. Maurel, S. Calabuig, A. Gutierrez, J. L. G. de Sande, et al. Deletions Affecting Codons 557-558 of the c-KIT Gene Indicate a Poor Prognosis in Patients With Completely Resected Gastrointestinal Stromal Tumors: A Study by the Spanish Group for Sarcoma Research (GEIS) J. Clin. Oncol., September 1, 2005; 23(25): 6190 - 6198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Corless, A. Schroeder, D. Griffith, A. Town, L. McGreevey, P. Harrell, S. Shiraga, T. Bainbridge, J. Morich, and M. C. Heinrich PDGFRA Mutations in Gastrointestinal Stromal Tumors: Frequency, Spectrum and In Vitro Sensitivity to Imatinib J. Clin. Oncol., August 10, 2005; 23(23): 5357 - 5364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Antonescu, P. Besmer, T. Guo, K. Arkun, G. Hom, B. Koryotowski, M. A. Leversha, P. D. Jeffrey, D. Desantis, S. Singer, et al. Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation Clin. Cancer Res., June 1, 2005; 11(11): 4182 - 4190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Tarn, E. Merkel, A. A. Canutescu, W. Shen, Y. Skorobogatko, M. J. Heslin, B. Eisenberg, R. Birbe, A. Patchefsky, R. Dunbrack, et al. Analysis of KIT Mutations in Sporadic and Familial Gastrointestinal Stromal Tumors: Therapeutic Implications through Protein Modeling Clin. Cancer Res., May 15, 2005; 11(10): 3668 - 3677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Saturday, J. Lasota, D. Frost, K. B. Brasky, G. Hubbard, and M. Miettinen KIT-positive Gastrointestinal Stromal Tumor in a 22-year-old Male Chimpanzee (Pan troglodites) Vet. Pathol., May 1, 2005; 42(3): 362 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Corless, L. McGreevey, A. Town, A. Schroeder, T. Bainbridge, P. Harrell, J. A. Fletcher, and M. C. Heinrich KIT Gene Deletions at the Intron 10-Exon 11 Boundary in GI Stromal Tumors J. Mol. Diagn., November 1, 2004; 6(4): 366 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Corless, J. A. Fletcher, and M. C. Heinrich Biology of Gastrointestinal Stromal Tumors J. Clin. Oncol., September 15, 2004; 22(18): 3813 - 3825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Wardelmann, A. Hrychyk, S. Merkelbach-Bruse, K. Pauls, J. Goldstein, P. Hohenberger, I. Losen, C. Manegold, R. Buttner, and T. Pietsch Association of Platelet-Derived Growth Factor Receptor {alpha} Mutations with Gastric Primary Site and Epithelioid or Mixed Cell Morphology in Gastrointestinal Stromal Tumors J. Mol. Diagn., August 1, 2004; 6(3): 197 - 204. [Abstract] [Full Text]
|
|
|
|
|
|
L. Boldrini, S. Ursino, S. Gisfredi, P. Faviana, V. Donati, T. Camacci, M. Lucchi, A. Mussi, F. Basolo, R. Pingitore, et al. Expression and Mutational Status of c-kit in Small-Cell Lung Cancer: Prognostic Relevance Clin. Cancer Res., June 15, 2004; 10(12): 4101 - 4108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Antonescu, A. Viale, L. Sarran, S. J. Tschernyavsky, M. Gonen, N. H. Segal, R. G. Maki, N. D. Socci, R. P. DeMatteo, and P. Besmer Gene Expression in Gastrointestinal Stromal Tumors Is Distinguished by KIT Genotype and Anatomic Site Clin. Cancer Res., May 15, 2004; 10(10): 3282 - 3290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Eisenberg and I. Judson Surgery and Imatinib in the Management of GIST: Emerging Approaches to Adjuvant and Neoadjuvant Therapy Ann. Surg. Oncol., May 1, 2004; 11(5): 465 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Kim, H. Lee, Y.-K. Kang, M. S. Choe, M.-H. Ryu, H. M. Chang, J. S. Kim, J. H. Yook, B. S. Kim, and J. S. Lee Prognostic Significance of c-kit Mutation in Localized Gastrointestinal Stromal Tumors Clin. Cancer Res., May 1, 2004; 10(9): 3076 - 3081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Heinrich, C. L. Corless, G. D. Demetri, C. D. Blanke, M. von Mehren, H. Joensuu, L. S. McGreevey, C.-J. Chen, A. D. Van den Abbeele, B. J. Druker, et al. Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor J. Clin. Oncol., December 1, 2003; 21(23): 4342 - 4349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. H. Segal, P. Pavlidis, C. R. Antonescu, R. G. Maki, W. S. Noble, D. DeSantis, J. M. Woodruff, J. J. Lewis, M. F. Brennan, A. N. Houghton, et al. Classification and Subtype Prediction of Adult Soft Tissue Sarcoma by Functional Genomics Am. J. Pathol., August 1, 2003; 163(2): 691 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Antonescu, G. Sommer, L. Sarran, S. J. Tschernyavsky, E. Riedel, J. M. Woodruff, M. Robson, R. Maki, M. F. Brennan, M. Ladanyi, et al. Association of KIT Exon 9 Mutations with Nongastric Primary Site and Aggressive Behavior: KIT Mutation Analysis and Clinical Correlates of 120 Gastrointestinal Stromal Tumors Clin. Cancer Res., August 1, 2003; 9(9): 3329 - 3337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schneider-Stock, C. Boltze, J. Lasota, M. Miettinen, B. Peters, M. Pross, A. Roessner, and T. Gunther High Prognostic Value of p16INK4 Alterations in Gastrointestinal Stromal Tumors J. Clin. Oncol., May 1, 2003; 21(9): 1688 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Levy, H. E. Remotti, W. M. Thompson, L. H. Sobin, and M. Miettinen From the Archives of the AFIP: Gastrointestinal Stromal Tumors: Radiologic Features with Pathologic Correlation RadioGraphics, March 1, 2003; 23(2): 283 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Frost, J. Lasota, and M. Miettinen Gastrointestinal Stromal Tumors and Leiomyomas in the Dog: A Histopathologic, Immunohistochemical, and Molecular Genetic Study of 50 Cases Vet. Pathol., January 1, 2003; 40(1): 42 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Fletcher, C. D.M. Fletcher, B. P. Rubin, L. K. Ashman, C. L. Corless, M. C. Heinrich, J. Andersson, H. Sjogren, J. Meis-Kindblom, G. Stenman, et al. KIT Gene Mutations in Gastrointestinal Stromal Tumors : More Complex than Previously Recognized? Am. J. Pathol., August 1, 2002; 161(2): 737 - 739. [Full Text] [PDF]
|
|
|
|
|
|
J. Lasota, J. Kopczynski, M. Majidi, M. Miettinen, and M. Sarlomo-Rikala Apparent KIT Ser715 Deletion in GIST mRNA Is Not Detectable in Genomic DNA and Represents a Previously Known Splice Variant of KIT Transcript Am. J. Pathol., August 1, 2002; 161(2): 739 - 741. [Full Text] [PDF]
|
|
|
|
|
|
C. L. Corless, L. McGreevey, A. Haley, A. Town, and M. C. Heinrich KIT Mutations Are Common in Incidental Gastrointestinal Stromal Tumors One Centimeter or Less in Size Am. J. Pathol., May 1, 2002; 160(5): 1567 - 1572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Heinrich, C. D. Blanke, B. J. Druker, and C. L. Corless Inhibition of KIT Tyrosine Kinase Activity: A Novel Molecular Approach to the Treatment of KIT-Positive Malignancies J. Clin. Oncol., March 15, 2002; 20(6): 1692 - 1703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Andersson, H. Sjogren, J. M. Meis-Kindblom, G. Stenman, P. Aman, and L.-G. Kindblom The Complexity of KIT Gene Mutations and Chromosome Rearrangements and Their Clinical Correlation in Gastrointestinal Stromal (Pacemaker Cell) Tumors Am. J. Pathol., January 1, 2002; 160(1): 15 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. V. Allander, N. N. Nupponen, M. Ringner, G. Hostetter, G. W. Maher, N. Goldberger, Y. Chen, J. Carpten, A. G. Elkahloun, and P. S. Meltzer Gastrointestinal Stromal Tumors with KIT Mutations Exhibit a Remarkably Homogeneous Gene Expression Profile Cancer Res., December 1, 2001; 61(24): 8624 - 8628. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
